期刊文献+

小细胞肺癌组织中突变型P53与Bcl-2蛋白的表达及意义 被引量:1

下载PDF
导出
摘要 目的探讨小细胞肺癌组织中突变型P53与Bcl-2蛋白的表达及意义。方法用SP免疫组化法检测40例小细胞肺癌组织中突变型P53与Bcl-2蛋白的表达情况,并将结果进行相关分析。结果小细胞肺癌组织中突变型P53与Bcl-2蛋白的阳性表达率明显高于正常肺组织(P<0.05)。突变型P53表达与淋巴结转移和TNM分期有关(P<0.05),而Bcl-2表达与之无关(P>0.05)。突变型P53与Bcl-2蛋白的表达有相关性(P<0.05)。结论小细胞肺癌组织中突变型P53蛋白与预后有关,Bcl-2蛋白与预后无关。
出处 《实验与检验医学》 CAS 2008年第1期45-46,共2页 Experimental and Laboratory Medicine
  • 相关文献

参考文献7

二级参考文献29

  • 1郭琳琅,曹长安,肖莎.抗凋亡基因bcl-2在鼻咽癌中的表达及意义[J].第一军医大学学报,1996,16(2):99-99. 被引量:8
  • 2李莉 孟刚 等.鼻咽癌中p53,bcl-2,bax,Fas的表达及其相互关系的研究[J].安徽医科大学学报,1999,34(6):479-479.
  • 3McVie JG.Non-small cell lung cancer:Meta-analysis of efficacy of chemotherapy[J].Semin Oncol,1996,23(3 Suppl 7):12-14.
  • 4Violette S,Poulain L,Dussaulx E,et al.Resistance of colon cancer cells to long-term 5-fluorouracil exposure is correlated to the relative level of bcl-2 and bcl-X(L) in addition to bax and p53 status[J].Int J Cancer,2002,98(4):498-504.
  • 5Borner MM,Brousset P,Pfanner MB,et al.Expression of apoptosis regulatory proteins of the bcl-2 family and p53 in primary resected non-small cell lung cancer[J].Br J Cancer,1999,79(5-6):952-958.
  • 6Steels E,Paesmans M,Berghmans T,et al.Role of p53 as a prognostic factor for survival in lung cancer:a systematic review of the literature with a Meta-analysis[J].Eur Respir J,2001,18(4):617-618.
  • 7Tanaka F,Yanagihara K,Ohtake Y,et al.p53 status predicts the efficacy of postoperative oral administration of tegafur for completely resected non-small cell lung cancer [J].Jpn J Cancer Res,1999,90(4):432-438.
  • 8Uramoto H,Osaki T,Inoue M,et al.Fas expression in non-small cell lung cancer:its prognostic effect in completely resected stage Ⅲ patients[J].Eur J Cancer,1999,35(10):1462-1465.
  • 9Sun SY,Yue P,Hong WK,et al.Induction of Fas expression and augmentation of Fas/Fas ligand-mediated apoptosis by the synthetic retinoid CD437 in human lung cancer cells[J].Cancer Res,2000,60(22):6537-6543.
  • 10Ohmori T,Podack ER,Nishio K,et al.Apoptosis of lung cancer cells caused by some anti-cancer agents (MMC,CPT-11,ADM) is inhibited by Bcl-2.Biochem Biophys Res Commun,1993,192(1):30-36.

共引文献15

同被引文献11

  • 1.Clinical importance of correlations between p53 immunoreactivity and clinicopathological parameters in lung carcinoma[J].Pathology & Oncology Research.1999(4)
  • 2Rawson NS,Peto J.An overview of prognostic factors in small cell lung cancer. A report from the Subcommittee for the Management of Lung Cancer of the United Kingdom Coordinating Committee on Cancer Research[].British Journal of Cancer.1990
  • 3Matsubara H,Takeuchi T,Nishikawa E, et al.Apoptosis induction by antisense oligonucleotides against miR-17-5p and miR-20a in lung cancers overexpressing miR-17-92[].Oncegene.2007
  • 4Gemba K,Ueoka H,Kiura K,et al.Immunohistochemical detection of mutant p53 protein in small-cell lung cancer: relationship to treatment outcome[].Lung Cancer.2000
  • 5Rodriguez-Salas N,Palacios J,Moreno G,et al.Correlation of p53oncoprotein expression with chemotherapy responsein small cell lung carcinomas[].Lung Cancer.2001
  • 6Zambetti GP.The p53 mutation "gradient effect" and its clinical implications[].Journal of Cellular Physiology.2007
  • 7Rosenfeld Mr,Malats N,Schramm h.Serum anti-p53 antibodies and prognosis of pantients with small-cell lung canceer[].Journal of the National Cancer Institute.1997
  • 8Lassen U,,Osterlind K,Hansen M, et al.Long-term survival in small-cell lungcancer:post treatment characteristics in patients surviving5to18+years—an analysisof1,714consecutive patients[].Journal of Clinical Oncology.1995
  • 9Yan HL,Xue G,Mei Q, et al.Repression of the miR-17-92 cluster by p53 has an important function in hypoxia-induced apoptosis[].EMBO Journal.2009
  • 10Zereu M,Vinholes JJ,Zettler CG.p53 and Bcl-2 protein expression and its relationship with prognosis in small-cell lung cancer[].Clinical Lung Cancer Journal.2003

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部